| Pharmaceutical active ingredients: |
| Tuberculin Protein Derivative Purified |
| Available forms, composition and doses of Tuberculin PPD Mantoux: |
| Injectable; Injection; Purified Protein Derivative of Tuberculin 1 tub / 0.1 mlInjectable; Injection; Purified Protein Derivative of Tuberculin 250 tub / 0.1 ml |
| Tuberculin PPD Mantoux medical category: |
| Human:Tuberculosis treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V04CF01 - Tuberculin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Tubecotubercid | Isoniazid | Unidentified Pharmaceutical Company |
| Tubenamide | Ethionamide | Unidentified Pharmaceutical Company |
| Tuberactinomycin B | Viomycin | Unidentified Pharmaceutical Company |
| Tuberbut | Tobramycin | Kampar Laboratorio; LKM Laboratorio |
| Tubercazon | Thioacetazone | Unidentified Pharmaceutical Company |
| Tuberculin PPD RT 23 | Tuberculin Protein Derivative Purified | Statens Serum Institute; DKSH |
| Tuberculin Tine Test | Tuberculin Old (Tuberculin Tine Test) | Lederle |
| Tubercuprose | Formic Acid | Unidentified Pharmaceutical Company |
| Tuberen | Isoniazid; Pyrazinamide; Rifampin | Upsifarma |
| Tuberex | Protionamide | Unidentified Pharmaceutical Company |